NYSE:HIMS Hims & Hers Health (HIMS) Stock Price, News & Analysis $21.72 -0.64 (-2.86%) (As of 03:08 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Hims & Hers Health Stock (NYSE:HIMS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Hims & Hers Health alerts:Sign Up Key Stats Today's Range$21.25▼$22.2850-Day Range$13.65▼$22.8052-Week Range$5.65▼$25.74Volume5.09 million shsAverage Volume8.20 million shsMarket Capitalization$4.67 billionP/E Ratio271.53Dividend YieldN/APrice Target$20.07Consensus RatingModerate Buy Company OverviewHims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.Read More… Crypto’s next big bull run? (Ad)Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on November 5. Just a day after the American election, Juan believes crypto could start a massive run up …And one special coin could do even better. Hims & Hers Health Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks64th Percentile Overall ScoreHIMS MarketRank™: Hims & Hers Health scored higher than 64% of companies evaluated by MarketBeat, and ranked 441st out of 1,022 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingHims & Hers Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 8 buy ratings, 8 hold ratings, and no sell ratings.Amount of Analyst CoverageHims & Hers Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Hims & Hers Health's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth68.18% Earnings GrowthEarnings for Hims & Hers Health are expected to grow by 68.18% in the coming year, from $0.22 to $0.37 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hims & Hers Health is 275.41, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 135.98.Price to Earnings Ratio vs. SectorThe P/E ratio of Hims & Hers Health is 275.41, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 142.10.Price to Book Value per Share RatioHims & Hers Health has a P/B Ratio of 13.68. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Hims & Hers Health's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted14.23% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently decreased by 6.71%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHims & Hers Health does not currently pay a dividend.Dividend GrowthHims & Hers Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted14.23% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently decreased by 6.71%, indicating that investor sentiment is improving significantly. News and Social Media2.5 / 5News Sentiment0.59 News SentimentHims & Hers Health has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 24 news articles for Hims & Hers Health this week, compared to 12 articles on an average week.Search InterestOnly 55 people have searched for HIMS on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.MarketBeat Follows26 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is an increase of 189% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $14,640,096.00 in company stock.Percentage Held by Insiders17.71% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Hims & Hers Health's insider trading history. Receive HIMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. Email Address HIMS Stock News HeadlinesHims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $47,738.99 in StockOctober 17 at 7:01 AM | insidertrades.comTop 3 Stocks with Explosive Call Option Activity: What to Watch (HIMS)Three stocks reported a surge in call option buying recently, showing investors that there could be a path to more upside potential, analysts agreeOctober 10, 2024 | marketbeat.comThe real reason Elon is fully endorsing TrumpElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. October 17, 2024 | Porter & Company (Ad)Hims & Hers Health, Inc. (NYSE:HIMS) CFO Oluyemi Okupe Sells 9,868 SharesOctober 9, 2024 | insidertrades.comHims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?There is now a new reason to look into Hims & Hers stock for additional upside, including the new addition to the S&P 600 index alongside double-digit growth.October 8, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Trading Up 4.4% Following Analyst UpgradeOctober 17 at 1:24 AM | americanbankingnews.comHims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk.October 16 at 8:16 PM | msn.comHims & Hers Health (NYSE:HIMS) PT Raised to $23.00 at Bank of AmericaOctober 16 at 4:11 AM | americanbankingnews.comSee More Headlines HIMS Stock Analysis - Frequently Asked Questions How have HIMS shares performed this year? Hims & Hers Health's stock was trading at $8.90 at the beginning of the year. Since then, HIMS shares have increased by 147.5% and is now trading at $22.03. View the best growth stocks for 2024 here. How were Hims & Hers Health's earnings last quarter? Hims & Hers Health, Inc. (NYSE:HIMS) announced its earnings results on Monday, August, 5th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. Hims & Hers Health's quarterly revenue was up 51.8% on a year-over-year basis. Who are Hims & Hers Health's major shareholders? Top institutional investors of Hims & Hers Health include Carnegie Investment Counsel (0.14%), Strategic Wealth Partners Ltd. (0.05%), SG Americas Securities LLC (0.03%) and Creative Planning (0.01%). Insiders that own company stock include Melissa Baird, David B Wells, Alex Bard, Michael Chi, Patrick Harrison Carroll, Soleil Boughton, Oluyemi Okupe, Jules A Maltz, Christopher D Payne, Andrew Dudum, Christiane Pendarvis, Irene Becklund, Lynne Chou O'keefe and Jack Abraham. View institutional ownership trends. How do I buy shares of Hims & Hers Health? Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Hims & Hers Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Hims & Hers Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Palantir Technologies (PLTR), Netflix (NFLX) and Palo Alto Networks (PANW). Company Calendar Last Earnings8/05/2024Today10/17/2024Next Earnings (Confirmed)11/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Offices & clinics of medical doctors Sub-IndustryHealthcare Current SymbolNYSE:HIMS CUSIPN/A CIK1773751 Webwww.forhims.com Phone415-851-0195FaxN/AEmployees1,046Year FoundedN/APrice Target and Rating Average Stock Price Target$20.07 High Stock Price Target$25.00 Low Stock Price Target$10.00 Potential Upside/Downside-10.2%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E Ratio279.53 Forward P/E Ratio101.64 P/E GrowthN/ANet Income$-23,550,000.00 Net Margins1.70% Pretax Margin1.98% Return on Equity5.25% Return on Assets4.06% Debt Debt-to-Equity RatioN/A Current Ratio2.68 Quick Ratio2.30 Sales & Book Value Annual Sales$1.07 billion Price / Sales4.50 Cash FlowN/A Price / Cash FlowN/A Book Value$1.61 per share Price / Book13.89Miscellaneous Outstanding Shares214,786,000Free Float176,747,000Market Cap$4.80 billion OptionableOptionable Beta1.06 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report This page (NYSE:HIMS) was last updated on 10/17/2024 by MarketBeat.com Staff From Our PartnersWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredThe Standard Oil of AI?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredElon Musk Drops Stunning Bombshell?Elon Musk just dropped a BOMBSHELL that could send shockwaves throughout the tech industry… While deliverin...Paradigm Press | SponsoredEquation for Profits: Volatility = OpportunityFREE Intro to Options Class Online Tonight Prosper Trading Academy | SponsoredTrump victory secured?According to the latest betting odds, Trump is a shoo-in for the White House. The former President now has ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.